Cell and Molecular Biology of Ovarian Cancer

Updates, Insights and New Frontiers

Inbunden, Engelska, 2024

3 649 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This volume, Cell & Molecular Biology of Ovarian Cancer, covers classic and modern cell and molecular biology as well as genetics, epigenetics, mitochondrial dysfunctions and apoptosis, cancer stem cells, angiogenesis, progression to metastasis, and treatment strategies including clinical trials related to ovarian cancer.

Produktinformation

Utgivningsdatum2024-05-29
Mått178 x 254 x 14 mm
Vikt475 g
FormatInbunden
SpråkEngelska
SerieAdvances in Experimental Medicine and Biology
Antal sidor128
FörlagSpringer International Publishing AG
ISBN9783031583100

Tillhör följande kategorier

Onkologi inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Gynekologi och obstetrik inom Medicin
Cellbiologi inom Naturvetenskap och teknik
Klinisk medicin och internmedicin inom Medicin

Dr. Heide Schatten is a cell and molecular biologist at the University of Missouri-Columbia. She specializes in reproduction and cancers of the reproductive systems. She has been involved as scientist adviser to advocates of Cancer Foundations and as a reviewer and study section leader of several Foundations and she has been a reviewer for the DOD prostate cancer program. She has had Cancer Research support and interacted with a large number of well-known cancer researchers including many from NIH Comprehensive Cancer Centers. Her publication record shows over 280 original publications and numerous review papers, many of which are focused on cell cycle and cytoskeletal abnormalities that are hallmarks for cancers including ovarian cancer. She has edited 19 previous books including (2013) Cell and Molecular Biology of Breast Cancer which has over 19,000 downloads.

Microtubule-targeting agents: disruption of the cellular cytoskeleton as a backbone of ovarian cancer therapy.- Tubulin complexity in cancer and metastasis.- The impact of centrosome pathologies on ovarian cancer development and progression with a focus on centrosomes as therapeutic target.- Drug-resistant epithelial ovarian cancer: current and future perspectives.- The role of the human microbiome in epithelial ovarian cancer.- Insights into the microbial composition of intratumoral, reproductive tract, and gut microbiota in ovarian cancer patients.- The impact of mitochondria in ovarian cancer cell metabolism, proliferation, and metastasis.